Tryngolza(Olezarsen) Side Effects

Common side effects of TRYNGOLZA include injection site reactions, decreased platelet count, and arthralgia.

Side Effects Associated with TRYNGOLZA  

The most common adverse reactions to TRYNGOLZA, based on clinical trial data, include injection site reactions, decreased platelet count, and arthralgia. Injection site reactions occurred in 19% of patients treated with TRYNGOLZA, significantly higher than the 9% observed in the placebo group. Decreased platelet count was noted in 12% of TRYNGOLZA-treated patients compared to 4% in the placebo group. Arthralgia was reported in 9% of patients. These reactions are generally mild to moderate but may require medical attention if severe or persistent. Patients should be closely monitored for these adverse events, particularly during the early stages of treatment.